U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07828704) titled 'Photodynamic Diagnosis of Kidney Cancer Using Fluorescence Endoscopy and Oral 5-ALA' on July 29.
Brief Summary: The goal of this prospective, single-arm feasibility study is to evaluate the safety and feasibility of using Gleolan(R) (5-aminolevulinic acid), an FDA-approved drug currently used during brain tumor surgery, in adults with suspected kidney cancer undergoing partial nephrectomy. Gleolan has shown promise in improving the visualization of cancerous tissue, and this study aims to assess its potential use in urologic oncology. The main questions it aims to answer are:
* Is Gleolan safe and well tolerated in patients with s...